Skip to content

Validation of the 'Suicidality: Treatment Occuring in Paediatrics (STOP) Suite of Measures' in Clinical and Non-clinical Child and Adolescent Populations

Validation of the 'Suicidality: Treatment Occuring in Paediatrics (STOP) Suite of Measures' in Clinical and Non-clinical Child and Adolescent Populations - STOP study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38610
Enrollment
250
Registered
2013-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatrische aandoeningen waarvoor een anti-psychoticum of anti-depressiva wordt voorgeschreven Psychiatric disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children and adolescents between the ages of 8 and 18 years old, and their parents or main carer. Children and adolescents newly treated with an antidepressant or cognitive behavior therapy for depression or antipsychotic medication for any indication (this inclusion criteria is for clinical population only). All parents and patients have provided informed consent/assent in accordance with ethical regulations.

Exclusion criteria

Exclusion criteria: If the main carer does not have a reasonable level of Dutch, they will be excluded from the study. This is because a reasonable level of Dutch is required to complete the baseline information. Children who are deemed by the clinician to be too vulnerable to participate (for clinical population only). The child/adolescent will be excluded if the main carer is not available to participate in the study.

Design outcomes

Primary

MeasureTime frame
The goal of this study is to develop a reliable and efficient screening tool for suicidal ideation and suicide risk in children and adolescents specifically addressed to capture the possible influence of medication side effects or mechanism of action. The rating scale will have one form for children and adolescents, one form to be addressed to their parents and another form to be completed by the clinician.

Secondary

MeasureTime frame
More specifically, the objectives are: 1. To design a rating scale for assessing suicidality in children and adolescents including developing different versions for children, parents, and clinicians 2. To translate the rating scales into all the languages of the countries collaborating in the study and to carry out a first evaluation of the psychometric properties of the resulting scales.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)